Artemis Medicare Services Statistics

Total Valuation

NSE:ARTEMISMED has a market cap or net worth of INR 37.16 billion. The enterprise value is 36.16 billion.

Market Cap	37.16B
Enterprise Value	36.16B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jul 5, 2024

Share Statistics

NSE:ARTEMISMED has 138.93 million shares outstanding. The number of shares has increased by 11.74% in one year.

Current Share Class	138.93M
Shares Outstanding	138.93M
Shares Change (YoY)	+11.74%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	2.50%
Owned by Institutions (%)	1.88%
Float	26.53M

Valuation Ratios

The trailing PE ratio is 50.37 and the forward PE ratio is 35.42.

PE Ratio	50.37
Forward PE	35.42
PS Ratio	3.97
PB Ratio	4.40
P/TBV Ratio	4.73
P/FCF Ratio	70.82
P/OCF Ratio	25.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.82, with an EV/FCF ratio of 68.93.

EV / Earnings	43.77
EV / Sales	3.86
EV / EBITDA	23.82
EV / EBIT	33.92
EV / FCF	68.93

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.34.

Current Ratio	2.49
Quick Ratio	2.30
Debt / Equity	0.34
Debt / EBITDA	1.91
Debt / FCF	5.53
Interest Coverage	3.34

Financial Efficiency

Return on equity (ROE) is 12.66% and return on invested capital (ROIC) is 6.98%.

Return on Equity (ROE)	12.66%
Return on Assets (ROA)	5.72%
Return on Invested Capital (ROIC)	6.98%
Return on Capital Employed (ROCE)	9.34%
Revenue Per Employee	4.71M
Profits Per Employee	414,996
Employee Count	1,991
Asset Turnover	0.80
Inventory Turnover	71.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.96% in the last 52 weeks. The beta is 0.26, so NSE:ARTEMISMED's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+52.96%
50-Day Moving Average	265.40
200-Day Moving Average	282.26
Relative Strength Index (RSI)	52.09
Average Volume (20 Days)	157,891

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ARTEMISMED had revenue of INR 9.37 billion and earned 826.26 million in profits. Earnings per share was 5.31.

Revenue	9.37B
Gross Profit	2.23B
Operating Income	1.07B
Pretax Income	1.08B
Net Income	826.26M
EBITDA	1.52B
EBIT	1.07B
Earnings Per Share (EPS)	5.31

Full Income Statement

Balance Sheet

The company has 3.96 billion in cash and 2.90 billion in debt, giving a net cash position of 1.05 billion or 7.58 per share.

Cash & Cash Equivalents	3.96B
Total Debt	2.90B
Net Cash	1.05B
Net Cash Per Share	7.58
Equity (Book Value)	8.44B
Book Value Per Share	53.47
Working Capital	3.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.46 billion and capital expenditures -931.51 million, giving a free cash flow of 524.65 million.

Operating Cash Flow	1.46B
Capital Expenditures	-931.51M
Free Cash Flow	524.65M
FCF Per Share	3.78

Full Cash Flow Statement

Margins

Gross margin is 23.84%, with operating and profit margins of 11.38% and 8.82%.

Gross Margin	23.84%
Operating Margin	11.38%
Pretax Margin	11.49%
Profit Margin	8.82%
EBITDA Margin	16.20%
EBIT Margin	11.38%
FCF Margin	5.60%

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.17%.

Dividend Per Share	0.45
Dividend Yield	0.17%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.23%
Buyback Yield	-11.74%
Shareholder Yield	-11.57%
Earnings Yield	2.22%
FCF Yield	1.41%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.

Last Split Date	Sep 23, 2021
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a